Let's talk about Press Releases.
I have found an inverse correlation between success and press releases (illustrated below). When I worked at Ellipse (MAGEC rods) we rarely wrote a press releases even while we doubled sales each year. Execution first. Blow the horn later.
Then, on the other hand, I see weak companies with no future spewing out press releases.
Great ortho companies don't need press releases. They quietly execute.
Crabby ortho companies issue press releases every chance they get to wash over their lack of execution.
Case in point - Kyphon issued very few press releases. Here is a their website in 2005. No news links.
Kyphon's early sales. They IPO'ed in 2002. This is what execution looks like.
1996 – First funding
1998 – FDA approves balloon kyphoplasty, but not the bone cement filler.
2000 – $6M sales
2001 – $36M sales
2002 – $76M
2003 – $131M
2004 – $306M (FDA approves the bone cement filler)
2005 – $408M
2007 – acquired for $3.9B
Case in point - Bone Biologics issued 2 press releases in the last week.
They filed for a new patent - nobody cares.They raised money - nobody cares.
Bone Biologics is a Zombie Ortho Company. They are a Class III company ...
